Crossmark

Effects of a smartphone application named “Shared Decision Making Assistant” for informed patients with primary liver cancer in decision-making in China: a quasi-experimental study

Crossref DOI link: https://doi.org/10.1186/s12911-022-01883-w

Published Online: 2022-05-31

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Sitong

Lu, Qingwen

Ye, Zhixia

Liu, Fang

Yang, Ning

Pan, Zeya

Li, Yu

Li, Li
Funding

Funding for this research was provided by:

Shanghai Municipal Planning Commission of Science and Research Fund (201640068)
License Information

Text and Data Mining valid from 2022-05-31

Version of Record valid from 2022-05-31
More Information

Article History

Received: 8 December 2021

Accepted: 16 May 2022

First Online: 31 May 2022

Declarations

:

: The trial was approved by the Institutional Research Ethics Committee of Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai China (Project Number: EHBHKY2019-K-008). And a written informed consent was obtained from all participants. We declared that all methods were carried out in accordance with the relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below